1. Home
  2. EDSA vs ATER Comparison

EDSA vs ATER Comparison

Compare EDSA & ATER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EDSA
  • ATER
  • Stock Information
  • Founded
  • EDSA 2015
  • ATER 2014
  • Country
  • EDSA Canada
  • ATER United States
  • Employees
  • EDSA N/A
  • ATER N/A
  • Industry
  • EDSA Biotechnology: Pharmaceutical Preparations
  • ATER Home Furnishings
  • Sector
  • EDSA Health Care
  • ATER Consumer Discretionary
  • Exchange
  • EDSA Nasdaq
  • ATER Nasdaq
  • Market Cap
  • EDSA 13.8M
  • ATER 15.5M
  • IPO Year
  • EDSA N/A
  • ATER N/A
  • Fundamental
  • Price
  • EDSA $2.18
  • ATER $1.36
  • Analyst Decision
  • EDSA Strong Buy
  • ATER
  • Analyst Count
  • EDSA 2
  • ATER 0
  • Target Price
  • EDSA $13.00
  • ATER N/A
  • AVG Volume (30 Days)
  • EDSA 22.9K
  • ATER 251.1K
  • Earning Date
  • EDSA 08-08-2025
  • ATER 08-07-2025
  • Dividend Yield
  • EDSA N/A
  • ATER N/A
  • EPS Growth
  • EDSA N/A
  • ATER N/A
  • EPS
  • EDSA N/A
  • ATER N/A
  • Revenue
  • EDSA N/A
  • ATER $94,191,000.00
  • Revenue This Year
  • EDSA N/A
  • ATER N/A
  • Revenue Next Year
  • EDSA N/A
  • ATER $7.48
  • P/E Ratio
  • EDSA N/A
  • ATER N/A
  • Revenue Growth
  • EDSA N/A
  • ATER N/A
  • 52 Week Low
  • EDSA $1.55
  • ATER $1.22
  • 52 Week High
  • EDSA $5.59
  • ATER $3.84
  • Technical
  • Relative Strength Index (RSI)
  • EDSA 60.86
  • ATER 39.29
  • Support Level
  • EDSA $1.89
  • ATER $1.46
  • Resistance Level
  • EDSA $2.23
  • ATER $1.56
  • Average True Range (ATR)
  • EDSA 0.11
  • ATER 0.11
  • MACD
  • EDSA 0.02
  • ATER -0.01
  • Stochastic Oscillator
  • EDSA 85.29
  • ATER 4.21

About EDSA Edesa Biotech Inc.

Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.

About ATER Aterian Inc.

Aterian Inc is a technology-enabled consumer products company. Its product categories include home and kitchen appliances, kitchenware, environmental appliances (dehumidifiers and air conditioners), beauty-related products and, consumer electronics. It has various owned and operates brands, including HomeLabs, Squatty Potty, Healing Solutions, PurSteam, and others. The company generates revenue through the online sales of various consumer products that are sold online.

Share on Social Networks: